Acasti Pharma to Report Third Quarter 2023 Financial Results on Tuesday, February 14, 2023
February 7, 2023
Adial Announces $5,000,000 Above Market Private Placement at $3.00 Per Share
July 7, 2021
Related Post
-
-
Coeptis Therapeutics and ShareIntel Enter Shareholder Service Agreement, Targeting Illegal Short Selling
February 7, 2023
-
First Wave BioPharma Regains Compliance With Nasdaq’s Minimum Bid Price Requirement
February 7, 2023
-
Silo Pharma Announces Expansion of Intellectual Property Portfolio
February 2, 2023